Regulus Therapeutics Inc.
METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
Last updated:
Abstract:
Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
Status:
Application
Type:
Utility
Filling date:
5 Oct 2021
Issue date:
27 Jan 2022